
Astral Analyst Review 2027: Revenue Up 26% but Margins Dip as the Stock Nears Its 52-Week Low
Updated: 20 Nov 2026 • 9:41 am
Posted by:

Astral Stock Snapshot (19 Nov 2026)
- Current Market Price (CMP): ₹1,254.40
- 52-Week High / Low: ₹1,768.70 / ₹1,215.50
- Market Capitalisation: ₹33,698 crore
- P/E Ratio vs Industry P/E: 59.3 vs 32.7
- Latest Quarter (Q2 FY27) Revenue: ₹2,000.1 crore
- Latest Quarter (Q2 FY27) Net Profit: ₹127.3 crore
Quick Answer: The Astral analyst review 2027 finds two named brokerage views after the Q2 FY27 results, both from November 2026: PL Capital (Buy, ₹1,595) and Motilal Oswal (Buy, ₹1,608), about 27% to 28% above the ₹1,254.40 close on 19 November 2026. Q2 consolidated revenue rose 25.9% to ₹2,000.1 crore, but EBITDA was nearly flat at ₹272.3 crore and net profit fell 5.6% to ₹127.3 crore. The stock is close to its 52-week low, so the Astral share price target 2027 rests on the margin recovery management expects in the second half.
The Astral analyst review 2027 covers Astral Ltd, the Ahmedabad-based company that introduced CPVC plumbing pipes in India and has since added adhesives, sealants, bathware and decorative paints. Readers searching for an Astral share price target 2027 will find fresh named brokerage notes from early November, which this review sets against the September quarter.
Astral closed at ₹1,254.40 on 19 November 2026, about 29% below its 52-week high of ₹1,768.70 and only about 3% above its low of ₹1,215.50. This Astral analyst review 2027 explains why strong sales did not lift profit and what shapes the Astral stock outlook 2027.
Click Here – Get Free Investment Predictions
What Analysts Say in the Astral Analyst Review 2027
| Brokerage | Rating | Target Price | Date |
|---|---|---|---|
| Motilal Oswal | Buy | ₹1,608 | November 2026 |
| PL Capital | Buy | ₹1,595 | November 2026 |
Both named target price figures were set on 6 November 2026, after the Q2 results, and sit about 27% to 28% above the current price. PL Capital nudged its sum-of-the-parts target up to ₹1,595 from ₹1,593, keeping its Buy rating despite the weaker quarter.
The brokerages point to plumbing volume growth, full pass-through of PVC price increases and protection from India's minimum import price on PVC. In this Astral analyst review 2027, the gap between the targets and the current price reflects confidence in a second-half margin recovery that the market has not yet priced in.
Q2 FY27 Results in the Astral Analyst Review 2027
| Metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Consolidated revenue | ₹2,000.1 crore | ₹1,588.8 crore | Up 25.9% |
| EBITDA | ₹272.3 crore | ₹268.2 crore | Up 1.5% |
| EBITDA margin | About 13.6% | About 16.9% | Down about 330 bps |
| Net profit | ₹127.3 crore | ₹134.8 crore | Down 5.6% |
| Standalone revenue | ₹1,772 crore | ₹1,416 crore | Up about 25% |
Revenue grew strongly as plumbing demand recovered after heavy destocking in the June quarter, and higher PVC prices lifted realisations. EBITDA margin fell by about 330 basis points because raw material costs rose before price increases fully reached customers.
Standalone net profit, which covers mainly the pipes business, rose slightly to ₹152.5 crore from ₹149.9 crore, while consolidated profit fell. In this Astral analyst review 2027, that gap points to weaker results in subsidiaries such as paints and adhesives.
How Astral Makes Money
Astral sells building products through a large dealer network, with plumbing pipes as the core business.
- Pipes and fittings: CPVC, PVC and specialised pipes for plumbing, drainage and agriculture.
- Adhesives and sealants: construction chemicals and adhesives under the Resinova business.
- Paints: decorative paints under the Gem brand, still in an investment phase.
- Bathware: faucets and sanitaryware sold through the same channel.
FY26 revenue rose to ₹6,615.9 crore from ₹5,873.7 crore, and net profit rose to ₹534.7 crore from ₹518.9 crore. Those numbers frame this Astral analyst review 2027, because revenue growth has outpaced profit growth for two years.
Management guides pipes and fittings volume growth of 10% to 13% in FY27 with EBITDA margins of 16% to 18%. It expects margins to improve in the December and March quarters from price pass-through, softer chemical inputs and better use of capacity, and said plumbing EBITDA improved in October. The Gem paints business targets 25% to 30% growth and aims to turn EBITDA-positive this year.
A CPVC resin plant is planned for commissioning in the March 2027 quarter, which would reduce reliance on imported resin. Large building material companies in the Sensex universe have also faced input cost swings this year, but Astral's premium valuation makes its share price more sensitive to margin misses. Operating cash flow was strong at about ₹1,117 crore in FY26 and debt is minimal.
Growth Triggers in the Astral Analyst Review 2027
- Volume recovery: plumbing demand improved after June quarter destocking.
- Margin outlook: management expects better margins in Q3 and Q4.
- PVC floor: the minimum import price limits downside in PVC prices.
- CPVC resin plant: commissioning planned for Q4 FY27.
- Brokerage support: November targets of ₹1,595 to ₹1,608 anchor the Astral share price target 2027.
Key Risks in the Astral Analyst Review 2027
- Raw material swings: PVC and chemical costs drive margins.
- Subsidiary drag: paints and adhesives weighed on consolidated profit.
- Valuation: about 59 times earnings against an industry level near 33.
- Competition: many pipe makers compete on price.
- Institutional selling: FII holding fell from 16.61% to 11.09%, a key point in the Astral analyst review 2027.
Compare Astral With Other Building Material Stocks on the Univest Screener
Astral Analyst Review 2027: Stock at a Glance
| Metric | Value |
|---|---|
| Share Price (19 Nov 2026) | ₹1,254.40 |
| 52-Week High / Low | ₹1,768.70 / ₹1,215.50 |
| Market Capitalisation | About ₹33,698 crore |
| P/E (TTM) | About 59.3 |
| Industry P/E | About 32.7 |
| Price to Book | About 7.95 |
| Return on Equity | About 13.4% |
| Debt to Equity | 0.08 |
| FY26 Revenue / Net Profit | ₹6,615.9 crore / ₹534.7 crore |
The P/E of about 59 is close to double the industry level, even after the share price fall. In this Astral analyst review 2027, the premium rests on Astral's brand strength and expected profit growth, which makes margin recovery essential.
Shareholding Trend
| Holder | Sep 2025 | Sep 2026 | Change |
|---|---|---|---|
| Promoters | 54.21% | 54.22% | Flat |
| Foreign Investors (FII) | 16.61% | 11.09% | Down 5.52 points |
| Domestic Institutions (DII) | 17.79% | 22.62% | Up 4.83 points |
| Public | 11.39% | 12.07% | Up 0.68 points |
Founder Sandeep Engineer holds 31.57% and the promoter stake was steady. Foreign investors sold more than five percentage points while domestic institutions bought nearly as much, a shift that the Astral analyst review 2027 links to the share price slide.
What to Watch After the Astral Analyst Review 2027
- Margins: recovery towards the 16% to 18% pipes guidance.
- Volumes: delivery on 10% to 13% pipes volume growth.
- Paints: progress towards EBITDA break-even at Gem.
- CPVC resin: start-up of the new plant in Q4 FY27.
- Revisions: updated notes on the Astral share price target 2027.
Final Word on the Astral Analyst Review 2027
The Astral analyst review 2027 shows strong revenue growth and recovering pipe demand, offset by weaker margins, subsidiary drag and foreign selling. Named November targets sit well above a share price that is near its 52-week low.
The Astral stock outlook 2027 depends on second-half margins and raw material costs. Univest does not give a buy or sell call.
Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions
What does the Astral analyst review 2027 show?
It shows strong sales but weaker profit. Q2 FY27 consolidated revenue rose 25.9% to ₹2,000.1 crore, while EBITDA rose only 1.5% to ₹272.3 crore. Net profit fell 5.6% to ₹127.3 crore.
What is the Astral share price target 2027 from brokerages?
Motilal Oswal has a Buy rating with a ₹1,608 target and PL Capital a Buy rating with a ₹1,595 target, both from 6 November 2026. These are about 27% to 28% above the ₹1,254.40 close on 19 November 2026. Both were set after the Q2 results.
Why did Astral's profit fall despite higher revenue?
Raw material costs rose before price increases fully reached customers, cutting EBITDA margin to about 13.6% from about 16.9%. Subsidiaries such as paints also weighed on consolidated profit. Standalone profit, mostly from pipes, rose slightly to ₹152.5 crore.
What guidance has Astral given for FY27?
Management expects pipes and fittings volume growth of 10% to 13% with EBITDA margins of 16% to 18%. It targets 25% to 30% growth in Gem paints and EBITDA break-even there. A CPVC resin plant is planned for the March 2027 quarter.
Is Astral stock expensive based on the Astral analyst review 2027?
The stock trades at about 59 times earnings, close to double the industry P/E of about 33. Return on equity is about 13.4% and debt is minimal. The premium relies on a recovery in margins and earnings growth.
What risks does the Astral analyst review 2027 highlight?
The main risks are PVC and chemical cost swings, weak results in subsidiaries and price competition among pipe makers. Foreign investors cut their stake from 16.61% to 11.09%. The high valuation leaves little room for misses.
What should investors track after the Astral analyst review 2027?
Track whether margins recover towards the 16% to 18% guidance in the second half. Watch pipe volume growth and progress at the Gem paints business. The start of the CPVC resin plant also matters.
Recent Articles

Asian Paints Analyst Review 2027: Revenue Up 17% but Margins Slip, Brokers Cluster Near ₹2,600
20 November 2026

Arvind Analyst Review 2027: Record Quarter as Advanced Materials and Dalco-GFT Lift Revenue 23%
20 November 2026

Ashoka Metcast Analyst Review 2027: Profit Rests on Other Income as Steel Sales Stay Small
20 November 2026

Ashima Analyst Review 2027: Sales Jump but a ₹20 Crore Loss Clouds the Turnaround Story
20 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Asian Paints Analyst Review 2027: Revenue Up 17% but Margins Slip, Brokers Cluster Near ₹2,600
Arvind Analyst Review 2027: Record Quarter as Advanced Materials and Dalco-GFT Lift Revenue 23%
Ashoka Metcast Analyst Review 2027: Profit Rests on Other Income as Steel Sales Stay Small
Ashima Analyst Review 2027: Sales Jump but a ₹20 Crore Loss Clouds the Turnaround Story
Automotive Stampings Analyst Review 2027: Sales Up 59% and Profit More Than Doubles
Popular this week
Asahi Songwon Analyst Review 2027: Profit Jumps Sevenfold as Pigment Sales Rise 66%

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





